메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

XtalPi Subsidiary Ailux Announces Strategic Collaboration with…

SHANGHAI, Nov. 5, 2025 -- Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and Company ("Lilly") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases. Through this collaboration, Lilly will gain access to Ailux's AI-powered bispecific antibody engineering platform, which integrates advanced structural modeling, generative design, and developability
- 김갑성 기자
- 2025-11-05 18:00
SingHealth Duke-NUS Launches Two New Global Health Centr…

The Centre for Global Allied Health and Centre for Global Pharmacy will advance global health collaboration and capacity building, with a focus on strengthening allied health and pharmacy practices across Asia. Both centres build on a legacy of more than 120 global health projects led by SingHealth and Duke-NUS partners, addressing urgent regional healthcare needs driven by ageing populations and rising chronic diseases. SINGAPORE, Nov. 5, 2025 -- The SingHealth Duke-NUS Academic Medical Centre today announced the establishment of two new centres — the Centre for Global
- 김갑성 기자
- 2025-11-05 15:43
제5회 세계보건포럼, 기후 변화를 공중보건의 중대 과제로 강조

[ 메디채널 김갑성 기자 ] 베이징 2025년 11월 5일 -- 11월 1일 베이징에서 개최된 제5회 세계보건포럼(World Health Forum)에서 22개 국가 및 지역의 전문가, 학자, 대표 약 400명이 모여 '기후 변화와 보건: 책임, 관리 체계, 그리고 인류의 공동 미래(Climate Change and Health: Responsibility, Governance and a Shared Future for Mankind)'라는 주제로 범세계적 보건 관리 체계를 마련할 방안을 모색했다. 반기문 보아오 아시아 포럼(Boao Forum for Asia) 의장이자 전 유엔(UN) 사무총장은 기조연설에서 기후 변화가 오늘날의 가장 시급한 공중보건 과제임을 강조하고 국제 사회에 기후 변화 대책을 범세계적 최우선 과제로 삼을 것을 촉구했다. 리루밍(Li Luming) 칭화대학교 총장은 인재를 양성하고, 과학 기술 혁신을 증진하며, 국제 협력을 강화하고, 인류 건강과 지속 가능한 발전을 지향하는 더 나은 미래를 한마음, 한뜻으로 보호할 수 있도록 사회 각계각층과 협력하게 되기를 기대한다고 밝혔다. 션훙빙(Shen
- 김갑성 기자
- 2025-11-05 15:15
KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Ho…

HONG KONG, Nov. 5, 2025 -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma (Hong Kong) Limited ('KLN Pharma'), as the fourth-party logistics (4PL) service provider for Australian skincare brand Ego Pharmaceuticals in Hong Kong. Under the partnership, KLN Pharma will manage Ego Pharmaceuticals' entire supply chain operations across a wide range of skincare and pharmaceutical products. KLN Pharma will oversee domestic distribution to Ego Pharmaceuticals' retail outlets, pharmacies, drugstores and key cha
- 김갑성 기자
- 2025-11-05 13:42
Ultra Maritime Provides Next Generation Torpedo Defence to Au…

ADELAIDE, Australia, Nov. 5, 2025 -- Ultra Maritime, the premier provider of torpedo defence and anti-submarine warfare solutions, has been selected to provide next generation torpedo defence capabilities for the Royal Australian Navy's (RAN) Hunter Class Frigate Program. This award adds to an expanding set of crewed and uncrewed vessels benefiting from Ultra Maritime's pioneering technologies. The Hunter class will deploy Ultra Maritime's Surface Ship Torpedo Defence (SSTD), combining a single in-line towed array with automatic threat alert for unparalleled performance, mainta
- 김갑성 기자
- 2025-11-05 10:48
NEC Drives the Future of Smart Living By Elevating Health, Cybers…

BANGKOK, Nov. 5, 2025 -- NEC Corporation (Thailand) Ltd. reafﬁrms its commitment to creating social value for Thailand by empowering cities, people, and businesses with advanced technology. Guided by NEC's global purpose to "create the social values of safety, security, fairness, and efficiency," the company presents breakthrough innovations aligned with four core pillars — Secure Society from Disaster, Value for Living, Value for Business, and Trust — at the Thailand Smart City Expo 2025, held on 5–7 November at the Queen Sirikit National Convention Center.
- 김갑성 기자
- 2025-11-05 09:19
Ascletis Presents Full Analysis of Phase Ib Study of ASC30 Oral…

[ 메디채널 김갑성 기자 ] -Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate gastrointestinal (GI) adverse events (AEs) across all multiple ascending dose (MAD) cohorts. -Phase Ib study data of ASC30 subcutaneous (SQ) injection showed that observed half-life reached 46 days for the treatment formulation (Injection A) and 75 days for the maintenance formulation (Injection B). -Combination of ASC47 and ASC31, a novel peptide agonist targeting both GLP-1R and GIPR, si
- 김갑성 기자
- 2025-11-05 08:10
Mölnlycke® establishes first wound care manufacturing site…

CHANGSHU, China and GOTHENBURG, Sweden, Nov. 5, 2025 -- Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound care manufacturing site in Changshu, China. This strategic investment marks a milestone in Mölnlycke's growth journey and the beginning of localised manufacturing in one of the world's fastest-growing MedTech markets. "Our site in Changshu marks another step forward in Mölnlycke's ambition to manufacture products closer to where they are sold. It reflects
- 김갑성 기자
- 2025-11-05 08:00
Angel Yeast starts Operating New 11,000-Ton Yeast Protein Pro…

YICHANG, China, Nov. 5, 2025 -- Angel Yeast Co., Ltd. (SH600298) has officially started operations at its next-generation yeast protein production line at the Baiyang Biotechnology Park in Yichang, Hubei. The facility has an annual production capacity of 11,000 tons of high-purity yeast protein with a protein content exceeding 80%. This marks a key step in meeting growing global demand for sustainable protein, significantly enhancing the company's global manufacturing footprint and reinforcing its leadership in the alternative protein and sustainable nutrition markets.
- 김갑성 기자
- 2025-11-05 07:52
Health In Tech Announces New Davos 2026 Panel: "First Lad…

STUART, Fla., Nov. 5, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced an expansion of its agenda for the Independent InsurTech Summit to be held during World Economic Forum Week 2026 in Davos, Switzerland. Following the previously announced CEO panel, "AI and Institutional Resistance: CEOs Driving Change in Legacy Sectors," Health In Tech will host a second session titled "First Ladies: Backing Women Who Build." The panel will spotlight global leaders advancing women's ent
- 김갑성 기자
- 2025-11-05 07:48

이전

41 42 43 44 45 46 47 48 49 50

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 21시 20분